Treatments for serious chronic diseases

In partnership with everyday experts

Our Disease Experience Expert Panels (DEEPs) are made up of people living with serious chronic diseases – including patients and family members. These experts by experience provide us with disease-specific insights into their daily and long-term challenges.

Such insights guide every aspect of the way we work: from our research and development of innovative treatments, to supporting people with serious chronic diseases to achieve better health and a better quality of life.

Meet the Disease Experience Expert Panels

Advance science and change lives – including your own

Our research and development is driven by the real-world experiences of people living with serious chronic diseases. Every year, more than 25,000 people participate in Novo Nordisk clinical trials, which we conduct in over 50 countries worldwide.

Sign up for one of our clinical trials. You can help our scientists discover more about new treatments that could one day benefit millions of people like you. You'll also learn about managing your own health and well-being.

Discover the benefits of clinical trial participation


Diabetes – what's going on in your body?


Understanding the connection between insulin, blood sugar and your average blood sugar levels over time – also known as HbA1c – is important for controlling type 2 diabetes.

Learn more at Diabetes What's next?


Breaking the weight-loss cycle


Obesity is a complex chronic disease that requires treatment. Weight management is about so much more than what you eat and how much you move. 

Discover the Truth About Weight


How to live with haemophilia?


Haemophilia is a rare and serious bleeding disorder. However, with proper treatment, children with haemophilia can look forward to a normal life expectancy.

Learn more about haemostasis management


Your child’s growth tells a story


Growth hormone deficiency affects childhood growth with life-long health consequences.



Find out why it's about More Than Height.